Department of Radiation Oncology, Ludwig-Maximilians-University Munich, Marchioninistr, 15, 81377 Munich, Germany.
Radiat Oncol. 2011 Nov 10;6:153. doi: 10.1186/1748-717X-6-153.
In order to define new prognostic subgroups in patients with glioblastoma a miRNA screen (> 1000 miRNAs) from paraffin tissues followed by a bio-mathematical analysis was performed.
35 glioblastoma patients treated between 7/2005 - 8/2008 at a single institution with surgery and postoperative radio(chemo)therapy were included in this retrospective analysis. For microarray analysis the febit biochip "Geniom® Biochip MPEA homo-sapiens" was used. Total RNA was isolated from FFPE tissue sections and 1100 different miRNAs were analyzed.
It was possible to define a distinct miRNA expression pattern allowing for a separation of distinct prognostic subgroups. The defined miRNA pattern was significantly associated with early death versus long-term survival (split at 450 days) (p = 0.01). The pattern and the prognostic power were both independent of the MGMT status.
At present, this is the first dataset defining a prognostic role of miRNA expression patterns in patients with glioblastoma. Having defined such a pattern, a prospective validation of this observation is required.
为了在胶质母细胞瘤患者中定义新的预后亚组,对石蜡组织进行了 miRNA 筛选(>1000 个 miRNA),然后进行生物数学分析。
本回顾性分析纳入了 35 名在单个机构接受手术和术后放化疗治疗的胶质母细胞瘤患者,这些患者于 2005 年 7 月至 2008 年 8 月间进行治疗。用于微阵列分析的是 febit biochip“Geniom® Biochip MPEA homo-sapiens”。从 FFPE 组织切片中分离总 RNA,分析 1100 个不同的 miRNA。
可以定义明确的 miRNA 表达模式,从而将不同的预后亚组分开。所定义的 miRNA 模式与早期死亡与长期生存(以 450 天为界)显著相关(p=0.01)。该模式及其预后能力均独立于 MGMT 状态。
目前,这是首个确定 miRNA 表达模式在胶质母细胞瘤患者中具有预后作用的数据集。在定义了这样的模式后,需要前瞻性验证这一观察结果。